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Cystatin could completely cure experimental visceral leishmaniasis by switching the
differentiation of Th2 cells to Th1 type, as well as upregulating NO, and activation of NF-jB
played a major role in these processes. Analysis of upstream signaling events revealed
that TLR 2/4-mediated MyD88-dependent participation of IL-1R-activated kinase (IRAK)1,
TNF receptor-associated factor (TRAF)6 and TGFb-activated kinase (TAK)1 is essential to
induce cystatin-mediated IjB kinase (IKK)/NF-jB activation in macrophages. Cystatin plus
IFN-c activated the IKK complex to induce phosphorylation-mediated degradation of p105,
the physiological partner and inhibitor of the MEK kinase, tumor progression locus 2 (Tpl-
2). Consequently, Tpl-2 was liberated from p105, thereby stimulating activation of the
MEK/ERK MAPK cascade. Cystatin plus IFN-c-induced IKK-b post-transcriptionally modi-
fied p65/RelA subunit of NF-jB by dual phosphorylation in infected phagocytic cells. IKK
induced the phosphorylation of p65 directly on Ser-536 residue whereas phosphorylation
on Ser 276 residue was by sequential activation of Tpl-2/MEK/ERK/MSK1. Collectively, the
present study indicates that cystatin plus IFN-c-induced MyD88 signaling may bifurcate at
the level of IKK, leading to a divergent pathway regulating NF-jB activation by IjBa
phosphorylation and by p65 transactivation through Tpl-2/MEK/ERK/MSK1.
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Introduction
Innate immunity coordinates the inflammatory response to
pathogens and the essential role of TLR in this is widely
recognized. Following infection, components of exogenous
pathogens bind to TLR on host cell, triggering the activation of
signaling pathways that stimulate the production of inflammatory
mediators such as pro-inflammatory cytokines, IFN and chemo-
kines. All these mediators are released into the circulation to elicit
effective immune response against invading microorganisms. All
TLR activate a common signaling pathway that culminates
in the activation of transcription factor NF-kB as well as MAPK
(ERK1/2, p38 and JNK) [1]. Following the recognition of
pathogen-associated molecular pattern, all of the TLR except
TLR3 recruit a signaling complex to the receptors that includes
an adaptor protein, MyD88 and two protein kinases, termed
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IL-1R-activated kinase (IRAK)1 and IRAK4 [2]. IRAK1 is then
phosphorylated by IRAK4 as well as by autophosphorylation
[3, 4], resulting in recruitment of TNF receptor-associated factor
(TRAF)6 [5]. Phosphorylated IRAK1 and TRAF6 are thought to
dissociate from the receptors [6], which is followed by TRAF6
autoubiquitination with lys-63-linked polyubiquitin chains [7].
TAB2 and TAB3, the regulatory subunits of the TGFb-activated
kinase (TAK) 1 complex, specifically interact with ubiquitinated
TRAF6, which activates TAK1 [8]. Activated TAK1 is then thought
to phosphorylate and activate downstream IkB kinase (IKK)
complex as well as MAPK kinase 6 to activate NF-kB and MAPK
signaling pathway. Activation of MAPK in macrophages requires
another serine/threonine kinase, tumor progression locus 2 (Tpl-
2) [9], also known as Cot/MAP3K8. Tpl-2 is critical for host
defense and appropriate cytokine response against pathogens like
Toxoplasma gondii and Listeria monocytogenes [10, 11]. It
functions as a MAPK kinase kinase, which phosphorylates and
activates MEK, the upstream activator of ERK1/2 kinase [12].
Tpl-2 is critically involved in linking TLR to TNF-a production
through its activation of ERK1/2 and also stimulates MEK
activation in presence of TNF-a and CD40 ligand, suggesting its
important role in both innate and adaptive immune response
[13]. In unstimulated macrophages, Tpl-2 is complexed with NF-
kB1 (p105), an IkB family member, which blocks its MEK kinase
activity [14, 15]. Stimulation of macrophages with LPS facilitates
the release of Tpl-2 from p105 and thereby activates its kinase
activity, which has been shown to occur as a consequence of p105
phosphorylation and proteolysis by the proteasome [14]. p105
phosphorylation is triggered by IKK complex, which is also critical
for regulating the activation of NF-kB transcription factors
through phosphorylation of IkB and p65/RelA subunit [15, 16].
Leishmaniases are spectrum of vector-borne parasitic diseases
that are a major international public health problem, affecting
the lives of millions of people worldwide with significant
morbidity and mortality [17]. Gene knock-out studies in mice
revealed an essential role of TLR signaling in the immune
responses against Leishmania parasites [18]. For instance,
MyD88-dependent pathway is required for the secretion of IL-1a
by mouse peritoneal macrophages following infection with
L. major [19] and MyD88-deficient mice developed progressive
lesion with dominant Th2 response [20]. In vivo studies in mice
revealed an important role for TLR4 in the control of L. major
infection, possibly through the early induction of iNOS [21].
TLR9 is involved in NK-cell activation and pro-inflammatory
cytokine synthesis in animal models of visceral (L. infantum) and
cutaneous (L. major and L. braziliensis) leishmaniasis [22, 23],
while Leishmania lypophosphoglycan, an abundant molecule on
the surface of promastigotes, signals via TLR 2 [24]. Moreover,
silencing of IRAK1, MyD88, TLR2 or TLR3 significantly atte-
nuated the secretion of nitric oxide and TNF-a following infection
of IFN-g-primed macrophages by L. donovani promastigotes [25].
In addition, a recent study suggests that TLR2 and MyD88
appeared to have a critical role in both recognition as well as
modulation of immune response against Leishmania parasites
[26]. Our earlier work showed that cystatin, a natural cysteine
protease inhibitor, in synergy with IFN-g, could completely cure
visceral leishmaniasis in BALB/c mice by inducing proin-
flammatory cytokine synthesis and NO generation [27].
Furthermore, this induction was found to be mediated by ERK 1/
2/mitogen- and stress-activated protein kinase 1 (MSK1) leading
to the activation of NF-kB-dependent gene expression [28]. In the
present study, we sought to determine the detailed upstream
signaling events involved in cystatin-induced activation of NF-kB,
which is essential for its anti-leishmanial effector response.
Results
Activation of NF-jB is essential for cystatin plus IFN-c-
mediated anti-leishmanial response
Cystatin could completely cure experimental visceral leishmania-
sis and this was shown to be associated with strong upregulation
of Th1 cytokine and iNOS [27]. In the in vitro situation, a sub-
optimal dose of IFN-g was required for cystatin-induced proin-
flammatory cytokine response and iNOS expression whereas IFN-g
was not a prerequisite in vivo. Because iNOS and many
proinflammatory gene expressions are regulated by NF-kB, the
effect of cystatin plus IFN-g on NF-kB activation was assessed in
infected macrophages using EMSA. DNA binding activity of NF-kB
was found to be markedly enhanced in infected BM-derived
macrophages (BMM) following cystatin plus IFN-g treatment,
being maximum at 4 h (3.8-fold) and still significant after 6 h (1.9-
fold) (Fig. 1A). For NF-kB nuclear translocation, cytoplasmic IkBa
must be phosphorylated, ubiquitinated and degraded. Because
IkBa is phosphorylated by the IKK multiprotein complex, the effect
of cystatin on the status of intrinsic cellular IKK activation was
assessed. Accordingly, L. donovani-infected macrophages were
treated with cystatin plus IFN-g; IKKb was immunoprecipitated
and tested for the ability to phosphorylate GST-IkBa substrate. As
shown in Fig. 1B, cystatin plus IFN-g strongly induced IKKb
activity in infected BMM. In order to further ascertain the role of
NF-kB in the modulation of disease progression, anti-leishmanial
activity of cystatin plus IFN-g was evaluated in the presence of
BAY 11-7082 or BAY 11-7085, chemical compounds that block
NF-kB expression by inhibiting IkB phosphorylation. In the in vitro
situation of amastigote multiplication within macrophages, BAY-
11-7082 (5mM) could substantially reverse the parasite killing
(78% reduction) by cystatin (Fig. 1C). In the in vivo situation of
L. donovani-infected BALB/c mice, administration of cystatin
(5mg/kg/day) plus IFN-g (5 105 U/kg/day) given for 4
consecutive days after 15 days of infection completely suppressed
the parasite burden in the spleen cells of mice (Fig. 1D). However,
a dose of 5mg/kg/day of BAY-11-7085 given three times weekly
for 4wk starting at 15 days after infection greatly reduced
cystatin-mediated protection (74% reduction in parasite killing).
In vivo administration of BAY-11-7085 could also result in marked
reduction of cystatin-mediated increase in TNF-a synthesis (77%
reduction) (Fig. 1E) as well as iNOS expression (4.3-fold
reduction) in infected mice (Fig. 1F). Taken together, these
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results strongly suggest that the therapeutic effect of cystatin may
be attributed to the activation of IKK-NF-kB pathway.
Cystatin plus IFN-c-induced Tpl-2/MEK/ERK pathway
Apart from activation of NF-kB, IKK is also known to induce
activation of Tpl-2, a serine-threonine kinase, which plays an
important role in both innate and adaptive immune response
[13, 14]. Since cystatin induced activation of IKK, we, therefore,
examined whether cystatin plus IFN-g could activate Tpl-2/MEK/
ERK pathway. Treatment of infected BMM with cystatin plus IFN-g
(060min) caused a marked increase in Tpl-2 kinase activity
reaching a maximum at 60min (Fig. 2A). The densitometric
analysis in the right-hand panel of immunoprecipitated Tpl-2
(consisting of p58 and p52 isoforms) demonstrated the disappear-
ance of p58 isoform at later time points (60 and 90min) (Fig. 2A)
suggesting its phosphorylation-mediated proteasomal degradation.
Figure 1. Involvement of NF-kB in cystatin plus IFN-g-mediated anti-leishmanial response. (A) BMM were infected with L. donovani promastigotes
(L. d) (cell:parasite ratio, 1:10) for 4 h. Noningested promastigotes were removed, and macrophages were cultured for another 20 h. L. donovani-
infected (24 h) BMM were further treated with cystatin (0.5 mM) plus IFN-g (100 U/mL) for 0–6 h and EMSA of NF-kB was performed with nuclear
extract. Extracts were also run with cold competitor oligonucleotides. Bands were analyzed densitometrically, and fold changes are indicated at
the bottom. (B) Whole-cell extracts from L. donovani-infected (24 h) and cystatin plus IFN-g-treated (1 h) BMM were immunoprecipitated with Ab
against IKKb. IKKb was assayed using GST-IkBa as substrate, and GST-phosphorylated IkBa was visualized by autoradiography. Relative amount of
IKKb in the whole-cell extracts was determined by Western blots. (C) Infected (24 h) and cystatin plus IFN-g-treated (24 h) BMM were pretreated
with BAY11-7085 (1 and 5mM) for 1 h. Intracellular parasite number was determined by Giemsa staining. (D) Mice were challenged with 107
promastigotes, and after 15 days of infection, they were treated with cystatin plus IFN-g daily for 4 consecutive days. Spleen parasite burdens were
determined weekly after infection and were expressed as the mean of log10LDU. SD for six animals per group. BAY11-7085 (5 mg/kg/day) was used
along with cystatin plus IFN-g in a separate set of experiments. (E and F) Infected mice were treated either with cystatin plus IFN-g or with cystatin
plus IFN-g plus BAY11-7085 as indicated in (D). ELISA was performed for the level of TNF-a (E) and real-time PCR analysis was performed for
the expression of iNOS (F) in the splenocytes. The cultures were set in triplicate and the experiments were done a minimum of three times.
Animal experiments were done with six animals per group and the results are representatives of four independent experiments. Data represent
the mean1SD. po0.01, po0.001; Student’s t-test.
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Proteasomal degradation of p58 isoform was further confirmed by
the use of MG 132, a proteasomal inhibitor, which almost
completely abrogated degradation of p58 as well as activation of
Tpl-2 in cystatin plus IFN-g-stimulated BMM (data not shown). This
was further reflected in the activation of downstream kinases, MEK
and ERK1/2. A marked phosphorylation of MEK and ERK1/2 were
found in infected cells following cystatin plus IFN-g treatment,
which was significantly abrogated (2.3- and 2.2-fold for MEK and
ERK1/2, respectively) in cells treated with Tpl-2-specific siRNA
(Fig. 2B). To further determine whether cystatin plus IFN-g induced
the dissociation of Tpl-2 from p105, cell lysates were pre-cleared of
p105 by immunodepletion and then subjected to Western blotting
with anti-Tpl-2 antibody. As depicted in Fig. 2C, very little p105-free
Tpl-2 was detected in infected cells. However, cystatin plus IFN-g
treatment induced the appearance of Tpl-2 in the p105-depleted
lysate of infected BMM (Fig. 2C) suggesting a release of Tpl-2 from
its inhibitor NF-kB p105. Moreover, the appearance of Tpl-2 in the
p105-depleted lysate peaked at 60min, the same time point at
which the Tpl-2 MEK kinase activity was maximum. Tpl-2 activation
is associated with p105 phosphorylation followed by its proteolysis.
We found that treatment of infected BMM with cystatin plus IFN-g
induced phosphorylation of p105 on serine 927 followed by its rapid
disappearance (Fig. 2D). The kinetics of p105 phosphorylation and
degradation was correlated with Tpl-2 release from p105. To further
address whether IKK is required for p105 phosphorylation as well as
activation of Tpl-2, BMM were treated with the IKK inhibitor BAY-
11-7082 prior to infection. Western blotting of cell lysates revealed
that this inhibitor blocked cystatin plus IFN-g-induced p105
phosphorylation and degradation (Fig. 2D). BAY-11-7082 also
blocked cystatin plus IFN-g-induced release of Tpl-2 from p105
(Fig. 2C) and Tpl-2 MEK kinase activity (Fig. 2F) in infected cells.
Moreover, cystatin plus IFN-g-mediated induction of MEK and ERK
phosphorylation were also significantly reduced by BAY-11-7082
treatment (Fig. 2E). Collectively, these data suggest that IKK activity
is required for cystatin plus IFN-g-mediated activation of Tpl-2/
MEK/ERK signaling pathway.
Cystatin plus IFN-c induced dual phosphorylation of
p65 by IKK
Phosphorylation of p65 at multiple residues has been implicated in
p65 nuclear translocation and transcriptional activation of NF-kB
[15, 16]. To investigate the possibility that IKK regulates NF-kB
by a mechanism involving p65 phosphorylation, infected BMM
were treated with cystatin plus IFN-g for different time periods
(03h). Immunoblot analysis showed a strong induction of p65
phosphorylation at both Ser-536 and Ser-276 residues (Fig. 3A),
Figure 2. Effect of cystatin plus IFN-g on Tpl-2/MEK/ERK pathway. (A) Infected BMM were treated with cystatin plus IFN-g for the indicated times.
Tpl-2 was immunoprecipitated and its MEK kinase activity was determined by coupled MEK/ERK kinase assay. Phosphorylated MBP substrate was
visualized by autoradiography and the levels of immunoprecipitated Tpl-2 were determined by Western blotting to normalize the kinase assay.
(B) RAW 264.7 cells were transfected (24 h) with either control or Tpl-2 siRNA, infected with L. donovani promastigotes (24 h) and further stimulated
with cystatin plus IFN-g for 4 h. The levels of p-MEK and p-ERK1/2 were measured by Western blotting. (C) L. donovani-infected BMM were treated with
cystatin plus IFN-g either alone or in combination with BAY11-7082 (5mM) (pretreated for 1 h) for the indicated times. p105-cleared cell lysates were
subjected to Western blotting for Tpl-2 and p105. (D) Infected BMM (24 h) were treated with cystatin plus IFN-g and BAY11-7082 as indicated in
(C). Levels of total and phosphorylated p105 were measured by immunobloting. (E) Infected BMM (24 h) were treated with cystatin plus IFN-g either
alone or in combination with BAY11-7082 (1 and 5mM) (pretreated for 1 h) for 4 h. Levels of p-MEK and p-ERK1/2 were measured by Western blotting.
(F) Infected BMM (24 h) were treated with cystatin plus IFN-g either alone or in combination with BAY11-7082 (1 and 5mM) (pretreated for 1 h) for 1 h.
Tpl-2 was immunoprecipitated from total-cell lysates and then assayed for MEK kinase activity as indicated in (A). Densitometries are shown as bar
graphs on the right-hand side of each panel. Results are expressed as mean1SD, n53. The results are representative of three separate experiments.
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which was maximum at 2h and almost completely abrogated in the
presence of IKK inhibitor BAY-11-7082, suggesting the involvement
of IKK in cystatin plus IFN-g-induced dual phosphorylation of p65
(Fig. 3B). The decrease in p65 phosphorylation was not due to p65
degradation because the level of p65 remained constant (Fig. 3B).
To further ascertain whether dual p65 phosphorylation was carried
out by IKK directly or by some intermediate kinase, BMM were
pretreated with apigenin, an inhibitor of ERK1/2 prior to cystatin
plus IFN-g stimulation. Interestingly, cell exposure to apigenin
markedly reduced the phosphorylation of p65 (3.6-fold) at Ser-276
residue whereas the level of Ser-536 phosphorylation was unaltered
(Fig. 3B). MSK1, a downstream target of ERK, phosphorylates
multiple substrates including Ser-276 of p65. As depicted in Fig. 3C,
phosphorylation of p65 at Ser-276 residue by cystatin was
significantly abrogated (3.2-fold) in infected cells transfected with
dominant-negative (dn) constructs of MSK1 with no alteration on
p65 Ser-536 phosphorylation. Moreover, MSK1 activity could be
significantly inhibited by apigenin (86%) and BAY11-7082 (91%)
(Fig. 3D) suggesting IKK-ERK-mediated MSK1 activation, which in
turn regulates Ser-276 phosphorylation of p65. Collectively, these
results suggest that IKK induced the phosphorylation of p65 directly
on Ser-536 residue and indirectly on Ser 276 residue by activation of
ERK/MSK1 in cystatin plus IFN-g-treated cells.
TAK1 is involved in cystatin plus IFN-c-mediated
NF-jB activation
The MAP3 kinase kinase kinase, TAK1 is known to mediate the
pathway leading to IKKa/b phosphorylation resulting in classic
NF-kB activation through IkB phosphorylation and degradation
[8]. We, therefore, examined the possibility of TAK1 involvement
in intermediate signaling events of cystatin plus IFN-g-induced
NF-kB activation. Kinetic analysis (0–60min) following stimula-
tion with cystatin plus IFN-g revealed time-dependent phosphory-
lation of TAK1 in both normal and infected BMM with lesser
induction and slower kinetics in infected cells (Fig. 4A). We
further analyzed the role of cystatin-mediated TAK1 induction on
both IKK activation and NF-kB-driven luciferase expression.
Transient transfection of RAW 264.7 cells with dn constructs of
TAK1 significantly reduced the amount of cystatin-induced
phospho-IkBa and prevented IkBa degradation (Fig. 4B) suggest-
ing a role of TAK1 in cystatin-mediated IKK activation. In
addition, overexpression of dn-TAK1 markedly inhibited cystatin
plus IFN-g-induced IKKb activity (Fig. 4C) as well as NF-kB-
driven luciferase expression (2.5-fold reduction) (Fig. 4D).
Cystatin-mediated anti-leishmanial activity was also significantly
decreased in infected cells (68% reduction in parasite killing)
transfected with dn TAK1 (Fig. 4E) implying the importance of
TAK1 in cystatin-mediated activation of NF-kB pathway.
TLR/MyD88-dependent activation of NF-jB is essential
for cystatin-mediated anti-leishmanial response
In the TLR/MyD88-signaling pathway, activated IRAK1 interacts
with TRAF6, which in turn leads to the activation of TAK1-
mediated NF-kB and MAPK [5, 6, 8] We, therefore, checked
whether MyD88-dependent signaling is necessary for cystatin-
induced activation of TAK1. To address this, RAW 264.7 cells
Figure 3. Role of cystatin plus IFN-g on p65 phosphorylation. (A) L. donovani infected (24 h) BMM were treated with cystatin plus IFN-g for the
indicated times. Cells were lysed and levels of p-ser536p65, p-ser276p65 and p65 were determined by Western blotting. (B) Infected cells (24 h) were
left untreated or pretreated with apigenin (40 mM) or BAY11-7082 (5 mM) for 1 h, followed by incubation with cystatin plus IFN-g for 2 h. Levels of
p-ser536p65, p-ser276p65 and p65 were determined by Western blotting. (C) Infected BMM (24 h) were transiently transfected with WT or dn-MSK1
expression plasmid. After 24 h of transfection, cells were stimulated with cystatin plus IFN-g for 2 h. Levels of p-ser536p65, p-ser276p65 and p65
were determined by Western blotting. (D) Infected cells were incubated with cystatin plus IFN-g for various time periods (0–120 min). In a separate
set of experiment, infected cells were treated with apigenin (40 mM) or BAY11-7082 (5 mM) for 1 h before treatment with cystatin plus IFN-g for
90 min. Cell lysates were then immunoprecipitated with anti-MSK1 Ab, and the immunoprecipitate was used to measure the phosphorylation of
CREBTIDE as described in Materials and methods section (n5 4). Bands were analyzed densitometrically. Error bars represent mean1SD, n5 3. The
data shown are representative of three independent experiments. po0.001; Student’s t-test.
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were transiently transfected with dn constructs of MyD88, IRAK1
and TRAF6. As demonstrated in Fig. 5A, cystatin plus IFN-g-
induced phosphorylation of TAK1 was significantly diminished in
infected macrophages overexpressing dn constructs of MyD88,
IRAK1 and TRAF6 (3.2-, 3.3- and 2.9-fold, respectively) suggest-
ing the involvement of MyD88-signaling in cystatin plus IFN-g-
mediated activation of TAK1. This was further reflected in
cystatin-induced downstream NF-kB luciferase activity, which
was substantially reduced in infected RAW 264.7 cells over-
expressing dn-MyD88 (2.7-fold), dn-IRAK (2.5-fold) and dn-
TRAF6 (2.6-fold) (Fig. 5B). Cystatin-induced inhibition of
amastigote multiplication was also found to be markedly
attenuated by overexpression of dn constructs of MyD88, IRAK1
and TRAF6 (73, 69 and 67% reduction in parasite killing,
respectively) (Fig. 5C). These results suggest that anti-leishma-
nial effect of cystatin required upstream involvement of MyD88,
IRAK and TRAF6. Since MyD88-dependent activation of NF-kB is
necessary to induce anti-leishmanial effector response by
cystatin, it might therefore induce the expression of TLR in
infected macrophages. We studied the expression of various TLR
in infected RAW 264.7 cells as well as BMM following cystatin
plus IFN-g treatment. As shown in Table 1, of all the TLR
examined, cystatin plus IFN-g led to a remarkable induction of
TLR2 (3.8-fold) and TLR4 (3.5-fold) expression in infected
macrophages at 12 h attaining maximal level at 24 h (8.3- and
8.7-fold for TLR2 and TLR4, respectively) and still significant
after 36 h (2.9- and 2.6-fold for TLR2 and TLR4, respectively).
The mRNA levels for remaining TLR did not change or were
marginally increased. The expression patterns of all TLR observed
in RAW 264.7 cells were similar to those observed in BMM (data
not shown). To further assess the possible role of TLR2 and 4 in
cystatin-mediated anti-leishmanial effector response, siRNA
mediated knock-down system was used. As shown in Fig. 5D,
transfection of RAW 264.7 cells with siRNA directed towards TLR
2 and TLR 4 significantly abrogated cystatin plus IFN-g-mediated-
NF-kB activation of luciferase expression (2.9- and 3.3-fold
reduction for TLR2 and 4, respectively) as well as parasite
suppressive effect (65 and 71% reduction in parasite killing for
TLR2 and 4, respectively) (Fig. 5E). In order to check the
presence of undetected contaminants in the parasite culture,
macrophages (106 cells) were stimulated with culture super-
natants obtained from 107 promastigotes grown at different time
periods. mRNA expression profiling of iNOS and TNF-a by real-
time PCR analysis after 24 h of incubation showed no alteration
in culture supernatant-treated macrophages as compared with
control macrophages (Fig. 5F). Since our cystatin preparation
contains 25 pg/mL LPS, we checked the iNOS and TNF-a
profiling in macrophages treated with IFN-g either alone or in
combination with LPS. LPS (30 pg/mL) plus IFN-g did not
significantly induce iNOS and TNF-a expression (1.2- and 1.35-
fold, respectively) compared with IFN-g alone suggesting thereby
that cystatin-mediated effect was not due to endotoxin contam-
ination (Supporting Information Fig. 1). Collectively, these
results suggest that TLR 2/4-MyD88-dependent activation of
Figure 4. Role of TAK1 in cystatin plus IFN-g induced NF-kB activation. (A) Both non-infected (upper row) and L. donovani-infected RAW 264.7 cells
(lower row) were treated with cystatin plus IFN-g for various time periods (0–90 min) and the levels of total and phosphorylated TAK1 were
measured by Western blot analysis. (B) Infected cells (24 h) were transiently transfected with wt or dn-TAK1 expression plasmid (24 h) and
stimulated with cystatin plus IFN-g for the indicated times. Levels of total and phosphorylated IkBa were determined by Western blot analysis.
(C) Infected macrophages were transfected with wt or dn-TAK1 expression plasmid for 24 h followed by stimulation with cystatin plus IFN-g for 1 h.
IKK activity was measured as described in the legend of Fig. 1B. (D) Infected macrophages (24 h) were transfected with pNF-kB-luciferase plasmid
(1 mg) and 0.5 mg of pCMV-b-galactosidase together with wt or dn-TAK1 expression plasmid. After 24 h of transfection, cells were stimulated with
cystatin plus IFN-g for 24 h, lysed and processed for luciferase activity (n5 4). (E) Infected cells were transfected with either wt or dn-TAK1
constructs, followed by treatment with cystatin plus IFN-g for 24 h. Intracellular parasite number was determined by Giemsa staining. Results are
representative of four individual experiments. Data represent mean1SD, n5 3. po0.001; Student’s t-test.
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NF-kB is essential for cystatin-induced anti-leishmanial effector
response.
Restoration of lys-63-linked ubiquitination of TRAF6
by cystatin
We then examined the integrity of the protein–protein interac-
tions between intracellular molecules of the TLR pathway
in infected and cystatin plus IFN-g-treated BMM. Because
binding of TAK1–TAB2 complex to TRAF6 is a crucial
step in the activation of TAK1 catalytic activity [6, 8], we
analyzed the association of TAK1–TAB2 complex to TRAF6 by
coimmunoprecipitation. Cell lysates from L. donovani-infected
and cystatin plus IFN-g-treated infected cells were subjected
to immunoprecipitation using an anti-TAB2 antibody and
immunocomplexes were analyzed by Western blotting with
anti-TAK1 and anti-TRAF6 antibody (Fig. 6A). TAK1 was
constitutively associated with TAB2 in both control and
L. donovani-infected cells. However, TRAF6 did not immunopre-
cipitate with TAB2 obtained from infected cells. In contrast,
cystatin plus IFN-g treatment rapidly induced coimmunoprecipi-
tation of TRAF6 with TAB2 from infected cells suggesting
association of TRAF6 with TAK1–TAB2 complex and thereby
activating TAK1-mediated IKK-NF-kB pathway. TLR signaling is
thought to induce TRAF6 aggregation resulting in TRAF6 auto-
ubiquitination at lys-63 residue, a required event for activation of
TAK1 and downstream signal transduction [7, 8]. The role of
TRAF6 ubiquitination is to provide an assembly scaffold for
binding of downstream components to lys-63 ubiquitin. We
observed that treatment of infected BMM with cystatin plus IFN-g
rapidly induced lys-63-linked polyubiquitination of TRAF6
(Fig. 6B), which is essential for its interaction and subsequent
activation of TAK1.
Figure 5. Effect of MyD88, IRAK1 and TRAF6 on cystatin plus IFN-g-induced anti-leishmanial response. (A) L. donovani-infected RAW 264.7 cells
were transiently transfected with wt or dn expression plasmids of MyD88, IRAK1 and TRAF6 for 24 h followed by stimulation with cystatin plus
IFN-g for 90 min. Levels of total and phosphorylated TAK1 were measured by Western blot analysis. (B) Infected cells were transiently transfected
with various constructs along with pNF-kB-luciferase plasmid (1 mg) as indicated in (A), followed by stimulation with cystatin plus IFN-g for 24 h,
lysed and processed for luciferase activity (n5 4). (C) Infected cells were transiently transfected with various constructs as indicated in (A),
followed by stimulation with cystatin plus IFN-g for 24 h. Intracellular parasite number was determined by Giemsa staining. To determine the
effect of TLR inhibition, macrophages were transfected (24 h) with TLR2 and TLR4 siRNA or control siRNA, infected and treated with cystatin plus
IFN-g as mentioned above. Cells were processed for luciferase activity (D) and intracellular parasite number was determined by Giemsa staining
(E). (F) L. donovani promastigotes were grown for different time periods. BMM (106 cells) were stimulated with promastigote (107)-culture
supernatants of each time point. iNOS and TNF-a mRNA expression were evaluated by real-time PCR analysis after 24 h of incubation. Experiments
were done at least three times each and one set of representative data is shown. Error bars represent mean1SD, n5 3. po0.001; Student’s t-test.
Table 1. Real-time PCR for various TLR in cystatin plus IFN-g-treated
macrophagesa)
Gene name Assay ID 12 h 24 h 36 h
TLR 1 Mm00446095_m1 1.470.2 1.670.4 1.370.3
TLR 2 Mm00442346_m1 3.870.4 8.371.1 2.970.4
TLR 3 Mm00446577_g1 1.570.3 1.870.5 1.670.3
TLR 4 Mm00445273_m1 3.570.6 8.771.2 2.670.5
TLR 5 Mm00546288_s1 1.170.3 1.370.5 1.770.4
TLR 6 Mm02529782_s1 1.570.4 1.770.6 1.270.3
TLR 7 Mm00446590_m1 1.170.3 1.470.5 1.570.4
TLR 8 Mm01157262_m1 1.370.4 1.670.3 1.470.5
TLR 9 Mm00446193_m1 1.270.3 1.470.4 1.770.3
TLR 11 Mm01701924_s1 0.970.3 1.170.4 1.370.4
a) Values are fold change relative to infected samples.
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Discussion
Parasites of the genus Leishmania rapidly alter several macro-
phage-signaling pathways in order to hijack the innate immune
response, thereby favoring their invasion and survival within the
host cell [29]. We previously elucidated the dual role of cystatin
in suppressing the functional differentiation of Th2 type CD41
T cells, leading to the augmentation of Th1 response, and also
upregulation of NO, resulting in the elimination of Leishmania
parasites in both in vitro and in vivo experimental models of
visceral leishmaniasis [27]. This was not related to cysteine
protease inhibitory activity because saturation of cysteine
protease inhibitory site by inactivated papain did not interfere
with cystatin-induced NO release from activated macrophages
[27]. Moreover, NO stimulatory site was different from cysteine
protease inhibitory site and was identified to be present on
the N-terminal 10-mer peptide sequence. This 10-mer peptide
mimicked the effect of the whole cystatin molecule both in terms
of NO upregulation and anti-leishmanial action [30]. We further
showed that cystatin acts on the host cell signaling machinery
resulting in the activation of MAPK pathway and transcription
factor NF-kB. This, in turn, leads to the generation of NO and pro-
inflammatory cytokines, which are responsible for the anti-
leishmanial activity of cystatin [28]. The residual LPS content
(o95pg/mL) present in our culture system may not be
significant in the present context as very negligible induction of
iNOS and TNF-a mRNA expression was observed in case of LPS
(100 pg/mL) plus IFN-g (100U/mL) treatment in L. donovani-
infected macrophages (Supporting Information Fig. 2). In the
present study we demonstrated that activation of NF-kB is
absolutely essential for inducing proinflammatory gene expres-
sion and analysis of upstream signaling events revealed that
TLR2/4 mediated MyD88-dependent participation of IRAK1-
TRAF6-TAK1 is necessary to induce cystatin-mediated IKK/NF-
kB activation in macrophages. In addition, cystatin activated the
IKK complex to phosphorylate p105, triggering its proteolysis.
Consequently, Tpl-2 is liberated from p105 thereby inducing
activation of the MEK/ERK MAPK cascade. Moreover, cystatin
plus IFN-g-induced IKKb post-transcriptionally modified p65/
RelA subunit by dual phosphorylation directly on Ser-536 and
indirectly on Ser-276 via Tpl-2/MEK/ERK/MSK1 sequence.
The importance of NF-kB in host defense against Leishmania
infection has been clearly established by studies in mice
deficient in different NF-kB family members [31]. NF-kB1 plays a
key role in the adaptive immune response to L. major
and is required for CD41 T-cell proliferation and development
of Th1 response [32]. In contrast, NF-kB2 and c-Rel are
involved in the innate responses to this intracellular pathogen
[33, 34]. Moreover, macrophage from c-Rel-null mice showed a
marked reduction in NO production and parasite killing
compared with that from WT mice [35]. We have also
demonstrated that cystatin might exert its curative effects on
leishmaniasis through its ability to activate NF-kB by IKK-medi-
ated IkB degradation resulting in in vivo induction of proin-
flammatory gene expression of TNF-a and iNOS. Moreover,
cystatin plus IFN-g induced the activation of Tpl-2, a
serine-threonine kinase regulated by IKK. Release of Tpl-2
occurred as a consequence of IKK-mediated phosphorylation and
subsequent proteolytic degradation of Tpl-2-associated p105.
The IKK-dependent mechanism of Tpl-2 activation raises
the question of the physiological advantage of linking
cystatin activation of ERK and NF-kB via MSK1. It was demon-
strated that induction of both TNF-a and COX-2 by LPS is
blocked in Tpl-2-deficient BMM due to impairment in the acti-
vation of the ERK MAPK cascade [9, 36]. Transcriptional
induction of both TNF-a and COX-2 by LPS involved co-ordinated
activation of ERK and NF-kB [37, 38]. In the present
study we observed that TNF-a synthesis and iNOS expression
in vivo are under the control of NF-kB signaling cascade in
cystatin-treated mice. Correlating the in vitro Tpl-2 activation
data with the in vivo activation of NF-kB by IKK, it seems
that ERK is activated simultaneously with NF-kB, facilitating
induction of proinflammatory gene expression by cystatin. In
addition, cystatin modulated IKK-induced phosphorylation of
NF-kB p65 subunit at Ser-536 and Ser-276 residues. This is in
accordance with a number of reports, which suggest that being a
p65/RelA kinase, IKK post-translationally modifies the p65
subunit by phosphorylation, thereby promoting the transcrip-
tional activation of NF-kB and the subsequent production of
inflammatory cytokines [15, 16]. TLR/MyD88-dependent
signaling is being implicated as essential for the immune
responses against Leishmania parasites. A recent report showed
Figure 6. Cystatin plus IFN-g-induced assembly of TRAF6–TAK–TAB complex. (A) L. donovani-infected (24 h) BMM were treated with cystatin plus
IFN-g for indicated times. The cells were lysed and subjected to immunoprecipitation and Western blot. IP: immunoprecipitation using the
indicated antibody; WB: Western blot analysis using the indicated antibody. (B) Infected (24 h) BMM were treated with cystatin plus IFN-g for the
indicated times. The cell lysates were immunoprecipitated with Anti-TRAF6 antibody and were analyzed for polyubiquitination state by Western
blot using a polyubiquitin-specific antibody. Bands were analyzed densitometrically and expressed as mean1SD, n5 3. Results are representative
of three individual experiments.
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that MyD88 was important for dendritic cell recognition of
L. braziliensis promastigotes in vitro and for the control of
infection in vivo because of significant impairments in T-cell
responses and protective immunity in MyD88/ mice [26].
Moreover, Leishmania could interfere with TLR signaling by
altering IRAK1’s capacity to dissociate from the MyD88 complex
[33]. Analysis of upstream signaling events in the present study
revealed that inhibition of MyD88, IRAK1 and TRAF-6 strongly
inhibited cystatin-induced NF-kB activation and parasite-
suppressive effect in infected RAW 264.7 cells. In addition,
cystatin-induced phosphorylation of TAK1 was substantially
reduced in infected cells transfected with dn constructs of
MyD88, IRAK1 and TRAF6. Since TAK1 is crucial for cystatin-
induced activation of IKK/NF-kB pathway, these observations
further strengthened the involvement of MyD88-dependent
signaling in cystatin-mediated NF-kB activation. TRAF6 belongs
to a member of E3 ubiquitin ligase family, and its auto-
ubiquitination with lys-63 linked chains is necessary for TAK1
activation and ligand induced NF-kB activation [7]. Cystatin plus
IFN-g caused rapid induction of lys-63 ubiquitination of TRAF6
for facilitating its interaction with TAK1–TAB complex and
thereby promoting activation of IKK-NF-kB pathway.
MyD88-dependent activation of NF-kB is primarily dictated by
TLR and a number of in vitro and in vivo studies have
already documented the importance of various TLR in host
defense against different forms of leishmaniasis [20, 21, 25].
Control of L. major replication correlates with the early induction
of iNOS in TLR4-competent mice, whereas increased parasite
survival in host cells from TLR4 null mice is associated with
higher activity of arginase, an enzyme essential for parasite
growth [21]. Binding of L. major lipophosphoglycan to TLR2
enhances IFN-g and TNF-a production and nuclear translocation
of NF-kB in human NK cells [24]. Cystatin plus IFN-g induced the
expression of TLR2 and 4 in infected phagocytic cells and silen-
cing of these receptors markedly attenuated the leishmanicidal
activity of cystatin thereby suggesting the importance of down-
stream MyD88-dependent signaling in anti-leishmanial effector
response.
In summary, the present study demonstrated that cystatin
plus IFN-g induced TLR/MyD88 signaling resulting in activation
of IKK complex. IKK, in turn, induced p65 transactivation via
Tpl-2/ERK pathway. TLR 2/4-induced IKK/NF-kB signaling in
association with p105-Tpl-2-ERK pathway steers the course of
cystatin-mediated host-protective immunological response in
experimental visceral leishmaniasis.
Materials and methods
Reagents, Ab and constructs
Chicken cystatin (egg white) was obtained from Sigma (St. Louis,
MO) and its purity is Z95% (GE). All Ab were purchased form
Cell Signaling Technology and Santa Cruz Biotechnology. BAY
11-7082 and BAY 11-7085 were obtained from Calbiochem. dn
MyD88 (152–296) and IRAK1 (1–217) were kindly provided
by Dr. M. Muzio, (Department of Immunology and Cell
Biology, Mario Negri Institute, Milan, Italy) [39, 40]. WT and
dominant-negative TRAF6 were gifts from Dr. J. Inoue (Institute
of Medical Science, University of Tokyo,Tokyo, Japan) [41]. dn
(K63W) TAK1 was a gift from K. Matsumoto (Nagoya
University, Nagoya, Japan) [42]. pCMV5-Flag-WT MSK1
(MSK1-Wt), pCMV-Flag-MSK1-A195/N-terminal kinase dead
(MSK1-Nd) were obtained from Dr D.R. Alessi (Medical Research
Council Protein Phosphorylation Unit, Department of Biochem-
istry, University of Dundee, Scotland, UK) [43]. All other
chemicals were purchased from Sigma-Aldrich unless otherwise
mentioned. The pNF-kB-luciferase plasmid containing five copies
of NF-kB consensus sequences (pNFkBLuc) were obtained from
Stratagene. A pCMV-b-galactosidase reporter vector was
purchased from Promega.
Parasites, cell culture and infection
The pathogenic strain of L. donovani promastigotes (MHOM/IN/
1983/AG83) were maintained as described previously [27]. BMM
were prepared, as described earlier [44], from the femurs and
tibias of 6–8wk old BALB/c mice. Splenocytes were cultured as
described previously [27]. The murine macrophage cell line RAW
264.7 was cultured in RPMI 1640 containing 10% FCS and
antibiotics as described previously [28]. In vitro infection
experiments were carried out with macrophages using stationary
phase promastigotes at a 10:1 parasite/cell ratio as described
earlier [28]. LPS was quantified by a sensitive colorimetric LPS
assay (QCL-1000, BioWhittaker, Walkersville, MD). LPS content
of the reagents (cystatin and IFN-g) was found to be less than
25 pg/mL. The concentration of LPS in media and FCS was less
than 30 pg/mL. The parasite cultures and the final culture
supernatants of cystatin plus IFN-g-treated infected BMM and
RAW 264.7 cells contained less than 95 pg LPS/mL.
In vivo priming and assessment of infection
Female BALB/c mice (20–25 g) were injected via the tail vein
with 107 L. donovani promastigotes. Cystatin (5mg/kg/day) in
combination with suboptimal dose of IFN-g (5 105 U/kg/day)
were administered through tail vein on the 15th day post-
infection for 4 consecutive days. Visceral infection was assessed
by removing spleen from infected mice; multiple impression
smears were prepared and stained with Giemsa. Spleen parasite
burdens, expressed as Leishman–Donovan units (LDU), were
calculated as the number of parasites per 1000 nucleated
cells organ weight (in grams) [27]. The investigation conforms
to the Guide for the Care and Use of Laboratory Animals
published by US National Institutes of Health (NIH Publication
No. 85-23 revised 1996) and with the approval of the Institu-
tional Animal Care and Use Committee.
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Real-time PCR
Total RNA was isolated from splenocytes, BMM or RAW
264.7 cells using the RNeasy Minikit (Qiagen) and quantitative
real-time PCR were performed as described earlier [44] using
TaqMan Fast Universal PCR Master Mix (Applied Biosystems).
TaqMan probes for all TLR (Table 1) and iNOS were also
purchased from Applied Biosystems. Relative quantitation was
performed using the comparative DDCt method according to the
manufacturer’s instructions.
ELISA
The level of TNF-a in the single-cell suspension of spleen cells was
measured as described previously using a sandwich ELISA Kit
(Quantikine M; R&D systems) [44].
IKK assay
Cystatin plus IFN-g-treated infected BMM were lysed in cold
kinase assay lysis buffer (20mM Tris-HCl, pH 8.0, 1mM EGTA,
1mM EDTA, 500mM NaCl, 10mM b-glycerophosphate, 10mM
NaF, 300 mM Na3VO4, 10mM pNPP, 1mM benzamidine, 2mM
PMSF, 10 mg/mL aprotinin, 1 mg/mL leupeptin, 1mg/mL pepsta-
tin, 1mM DTT and 0.25% Nonidet P-40). IKK activity was
measured as described earlier [45]. Briefly, the cell lysates
(300 mg) were immunoprecipitated with anti-IKKb Ab in immu-
noprecipitation buffer [45] followed by incubation with recom-
binant IkBa (4 mg) in kinase buffer [45] at 301C for 1 h. The
kinase reaction was stopped by addition of SDS-sample buffer.
For visualization of phosphorylated IkBa, the reaction was
subjected to SDS PAGE, dried and autoradiographed. Quantifica-
tion of the radioactive bands was performed with a Phosphor-
Imager. Western blotting for IKKb was performed as a loading
control by using anti-IKKb antibody.
EMSA
Nuclear extracts from BMM were isolated and EMSA for NF-kB
was performed as described earlier [45].
Tpl-2 kinase assay
To assay Tpl-2 MEK kinase activity, BMM (107 cells) were plated
in 90-mm dishes (Nunc). After appropriate treatment, cells were
washed with ice-cold PBS, lysed in 1mL of kinase lysis buffer
(Cell Signaling) and immunoprecipitated with agarose coupled
anti-Tpl-2 antibody (Santa Cruz Biotechnology). After 4 h of
incubation at 41C, beads were washed four times with lysis
buffer, twice with kinase buffer then resuspended in 25 mL of
kinase buffer containing 1mM ATP, 0.5 mg of GST-MEK1 (Upstate
Biotechnology) and 1mg of GST-ERK (Upstate Biotechnology).
The beads were incubated on a shaker at 301C for 30min,
pelleted and 4 mL of the supernatant was added to a reaction mix
containing 10 mL of kinase buffer, 0.1 mM ATP, 50 mg of myelin
basic protein (MBP) (Upstate Biotechnology), 10 mCi [g-32P] ATP
and incubated at 301C for 10min. The assay was terminated by
adding 2 SDS sample buffer and labeled MBP was visualized by
autoradiography. Tpl-2 bound to agarose beads was eluted with
0.2M glycine (pH 2.4) and analyzed by immunoblotting to
normalize the kinase assay.
Immunoprecipitation and Western blot
To analyze p105-free Tpl-2, lysates were first immunodepleted
twice for 2 h with p105 antibody or control immunoglobulin
coupled to protein A-Sepharose. Subsequently, these cleared
lysates were immunoprecipitated with anti-Tpl-2 antibody, anti-
p105 antibody or control IgG. Immunoblot was performed as
described previously [28]. Densitometric analyses for all experi-
ments were carried out using QUANTITY ONE software (Bio-Rad,
Hercules, CA, USA). Band intensities for immunoblots were
normalized to b-actin and expressed in arbitrary units.
MSK1 activity assay
MSK1 assay was performed as described previously [28]. In vitro
kinase assays were carried out on MSK1 immunoprecipitates
using the synthetic peptide EILSRRPSYRK (CREBTIDE) as
substrate. Kinase activity is expressed in c.p.m. of [32P] ATP
incorporated in the substrate.
Transient transfection and NF-jB reporter assay
RAW 264.7 cells (2106) were transfected with the appropriate
constructs along with luciferase reporter plasmid and b-galacto-
sidase reporter expression vector as described previously [28].
For promoter activation analysis, luciferase activity assays were
performed in a luminometer, and the results were normalized for
transfection efficiencies by assay of b-galactosidase activity. For
siRNA transfection, cells were transfected with 1mg of appro-
priate siRNA or control siRNA according to the manufacturer’s
instructions (Santa Cruz Biotechnology).
Statistical analysis
Data shown are representative of at least three independent
experiments unless otherwise stated as n values given in the
legend. Macrophage cultures were set in triplicate and the results
are expressed as the mean7SD. Statistical significances of
differences among pair of data sets were determined by Student’s
t test with a p value o0.05 considered to be significant.
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